Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Utilizing AI-based methodologies for identifying metabolic dysfunction-related steatotic liver disease, evaluating fibrosis, and determining hepatocellular carcinoma risk: a comprehensive review

  • By

  • Anvitha Nagaraj Sharma

  • Hima Bhagavatula

  • Michael T. Mapundu

  • Emile R. Chimusa

  • July 1, 2026

Share

Original Source(s)

Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review

  • by Anvitha Nagaraj Sharma, Hima Bhagavatula, Michael T. Mapundu, Emile R. Chimusa

  • July 1, 2026

Related Content

Anatomical site and histological subtype as determinants of Breslow thickness and high-risk features in surgically managed cutaneous melanoma at Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa

Venetoclax plus azacitidine in higher-risk myelodysplastic syndromes: a treatment-purpose framework for interpreting response depth

Transitioning from hand-sewn to circular stapled cervical anastomosis after minimally invasive esophagectomy: a Western centre propensity score matching analysis